These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34889556)

  • 1. Effects of lansoprazole capsule combined with mosapride citrate tablets on gastric motility, VIP and PG in patients with symptomatic gastroesophageal reflux disease.
    Zhao H; Li Y
    Minerva Surg; 2022 Dec; 77(6):623-624. PubMed ID: 34889556
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect analysis on Deanxit combined with Shuganjieyu capsule in the treatment of refractory gastroesophageal reflux disease].
    Yang XY; Guo CY; Zhang X; Zhong YQ; Tian C
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(44):3475-3479. PubMed ID: 29275582
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of preferences in patients with gastroesophageal reflux disease and dysphagia concerning treatment with lansoprazole orally disintegrating tablets].
    Blanco MA; Prieto M; Mearin F; Plazas MJ; Armengol S; Heras J; Mas M; Piqué JM;
    Gastroenterol Hepatol; 2009 Oct; 32(8):542-8. PubMed ID: 19595483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying.
    Futagami S; Iwakiri K; Shindo T; Kawagoe T; Horie A; Shimpuku M; Tanaka Y; Kawami N; Gudis K; Sakamoto C
    J Gastroenterol; 2010 Apr; 45(4):413-21. PubMed ID: 19997942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis.
    Hsu YC; Yang TH; Hsu WL; Wu HT; Cheng YC; Chiang MF; Wang CS; Lin HJ
    Br J Clin Pharmacol; 2010 Aug; 70(2):171-9. PubMed ID: 20653670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease.
    Yamaji Y; Isomura Y; Yoshida S; Yamada A; Hirata Y; Koike K
    J Dig Dis; 2014 Sep; 15(9):469-76. PubMed ID: 24957863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of mosapride citrate and lansoprazole for prevention of aspiration pneumonia in patients receiving gastrostomy feeding.
    Takatori K; Yoshida R; Horai A; Satake S; Ose T; Kitajima N; Yoneda S; Adachi K; Amano Y; Kinoshita Y
    J Gastroenterol; 2013 Oct; 48(10):1105-10. PubMed ID: 23238778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia.
    Kinoshita Y; Miwa H; Sanada K; Miyata K; Haruma K
    J Gastroenterol; 2014 Apr; 49(4):628-37. PubMed ID: 23653056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease.
    Ruth M; Hamelin B; Röhss K; Lundell L
    Aliment Pharmacol Ther; 1998 Jan; 12(1):35-40. PubMed ID: 9692698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastroesophageal reflux disease.
    Fiedorek S; Tolia V; Gold BD; Huang B; Stolle J; Lee C; Gremse D
    J Pediatr Gastroenterol Nutr; 2005 Mar; 40(3):319-27. PubMed ID: 15735486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mosapride for gastroesophageal reflux disease in neurologically impaired patients.
    Komura M; Kanamori Y; Tanaka Y; Kodaka T; Sugiyama M; Terawaki K; Suzuki K; Iwanaka T
    Pediatr Int; 2017 Mar; 59(3):347-351. PubMed ID: 27561215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired gastric motility and its relationship to reflux symptoms in patients with nonerosive gastroesophageal reflux disease.
    Kamiya T; Adachi H; Hirako M; Shikano M; Matsuhisa E; Wada T; Ogasawara N; Nojiri S; Kataoka H; Sasaki M; Ohara H; Joh T
    J Gastroenterol; 2009; 44(3):183-9. PubMed ID: 19214661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of mosapride on oesophageal motor function and acid reflux in patients with gastro-oesophageal reflux disease.
    Ruth M; Finizia C; Cange L; Lundell L
    Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1115-21. PubMed ID: 14501621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Janczewska I; Sagar M; Sjöstedt S; Hammarlund B; Iwarzon M; Seensalu R
    Scand J Gastroenterol; 1998 Dec; 33(12):1239-43. PubMed ID: 9930385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized study of lafutidine vs lansoprazole in patients with mild gastroesophageal reflux disease.
    Takenaka R; Okada H; Kawano S; Komazawa Y; Yoshinaga F; Nagata S; Inoue M; Komatsu H; Onogawa S; Kushiyama Y; Mukai S; Todo H; Okanobu H; Manabe N; Tanaka S; Haruma K; Kinoshita Y
    World J Gastroenterol; 2016 Jun; 22(23):5430-5. PubMed ID: 27340360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mosapride combined with esomeprazole improves esophageal peristaltic function in patients with gastroesophageal reflux disease: a study using high resolution manometry.
    Cho YK; Choi MG; Park EY; Lim CH; Kim JS; Park JM; Lee IS; Kim SW; Choi KY
    Dig Dis Sci; 2013 Apr; 58(4):1035-41. PubMed ID: 23053900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of mosapride plus proton pump inhibitors for treatment of gastroesophageal reflux disease: a systematic review.
    Liu Q; Feng CC; Wang EM; Yan XJ; Chen SL
    World J Gastroenterol; 2013 Dec; 19(47):9111-8. PubMed ID: 24379638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaled breath condensate pH does not discriminate asymptomatic gastroesophageal reflux or the response to lansoprazole treatment in children with poorly controlled asthma.
    Fitzpatrick AM; Holbrook JT; Wei CY; Brown MS; Wise RA; Teague WG;
    J Allergy Clin Immunol Pract; 2014; 2(5):579-86.e7. PubMed ID: 25213052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of mosapride citrate in proximal gastric accommodation and gastrointestinal motility in healthy volunteers: a double-blind placebo-controlled ultrasonographic study.
    Kusunoki H; Haruma K; Hata J; Kamada T; Ishii M; Yamashita N; Inoue K; Imamura H; Manabe N; Shiotani A
    J Gastroenterol; 2010 Dec; 45(12):1228-34. PubMed ID: 20658155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability.
    Gunasekaran T; Gupta S; Gremse D; Karol M; Pan WJ; Chiu YL; Keith R; Fitzgerald J
    J Pediatr Gastroenterol Nutr; 2002; 35 Suppl 4():S327-35. PubMed ID: 12607793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.